CSM Technologies IPO opens: Check brokerage review, GMP and other detailsThe IPO will remain open until June 26. It is a book-built issue with a price band of Rs 147-155 per share. The issue comprises a fresh iss...
24 Jun, 2026, 10.08 AM IST
Advit Jewels IPO booked over 6.5x on Day 1 so far; all categories oversubscribed; GMP signals 47% listing gainsJaipur's Advit Jewels is experiencing a robust IPO debut, with investor demand surging on day one, leading to a 6.75 times subscription. Th...
23 Jun, 2026, 02.13 PM IST
Should long term investors bet on Waterways Leisure IPO?Ocean cruise operator Waterways Leisure Tourism is set to raise ₹585 crore for expansion and lease payments. Despite operating a single ves...
23 Jun, 2026, 06.18 AM IST
Advit Jewels IPO opens tomorrow: GMP at 47%; SBI Securities recommends 'Subscribe'Jaipur's handcrafted jewellery maker, Advit Jewels, is set to launch its IPO on June 23, 2026, with strong grey market interest indicating ...
22 Jun, 2026, 11.51 AM IST
ETMarkets PMS Talk | 20 months of consolidation has created compelling small-cap opportunities: Equitree’s Pawan BharaddiaIn an interaction with Kshitij Anand of ETMarkets, Bharaddia explains why his firm continues to follow a private equity-style investing app...
20 Jun, 2026, 12.18 PM IST
Leader's Premium: The math behind Jio Platforms' priceJio Platforms' upcoming IPO is priced at a premium, reflecting its market leadership and advanced 4G/5G network. Despite smaller revenues t...
20 Jun, 2026, 07.45 AM IST
Growth over scale: NSE is priced at a discount to BSENSE's upcoming IPO is set for a discount compared to its peer BSE. This valuation reflects slower growth in NSE's core business. BSE, howev...
19 Jun, 2026, 05.39 AM IST
AI boom hands HFCL investors nearly 200% returns in just 6 months. Overheated or undervalued?HFCL shares have surged nearly 200% in six months, driven by the AI boom and India's expanding data centre industry. The company, a key opt...
17 Jun, 2026, 09.52 AM IST
Beyond Vedanta: The other Anil Agarwal stock that just exploded 500% on AI boomSterlite Technologies, a Vedanta-backed optical fibre manufacturer, has witnessed an extraordinary 500% surge in its stock value in 2026, d...
16 Jun, 2026, 10.08 AM IST
Nifty’s hidden discount sale: 54% of top Indian stocks are cheaper now than in 2023. Is it time to buy?Over half of India's top Nifty50 stocks are now trading at lower forward P/E multiples than in 2023, indicating a significant valuation cor...
15 Jun, 2026, 09.27 AM IST
C’mon SEBI, step out & save: The market regulator should fix flawed IPO rules to stem inflated valuations, and capital flightCoca-Cola may list on Indian stock exchanges next year, a significant shift after 50 years. This move could expose inflated valuations due ...
12 Jun, 2026, 02.21 PM IST
Dabur India shares in focus after US FDA places drugs from Silvassa plant under import alert. Here’s whyDabur India shares are set to be in focus after the US FDA issued an import alert on drugs manufactured at its Silvassa plant, citing data ...
12 Jun, 2026, 09.19 AM IST
ET Explainer: Why largecaps are gaining appeal as Nifty consolidatesWith Nifty 50 valuations at long-term averages, wealth managers suggest allocating to large-cap stocks. These companies offer stability and...
10 Jun, 2026, 07.36 AM IST
RVNL shares jump 3% after securing Rs 221 crore Railway contractRVNL shares saw an uptick on Tuesday after the company secured a Rs 221.33 crore railway signalling and infrastructure upgrade contract fro...
09 Jun, 2026, 10.19 AM IST
Attractive valuations, improving earnings: Why fund managers are now raising their exposure to small-cap stocksMidcap stocks have dominated performance for a decade, but a shift towards small caps is emerging. Flexi-cap funds are increasing small-cap...
08 Jun, 2026, 11.25 AM IST
Can CMR Green's IPO deliver long-term gains for high-risk investors?CMR Green Technologies, a non-ferrous metal recycler, plans to raise ₹630 crore via an offer for sale. The company, heavily reliant on recy...
03 Jun, 2026, 06.43 AM IST
Zaynich's blockbuster potential lifts Wockhardt's long-term outlookWockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...
02 Jun, 2026, 05.48 AM IST